Blue Trust Inc’s Meridian Bioscience Inc VIVO Stock Holding History

Blue Trust Inc’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,487	Closed	-$49K	–	2668
2023 Q1	$49K	Sell	1,487 -78	-5%	-$2.63K	﹤0.01%	1047
2022 Q4	$49K	Buy	1,565 +934	+148%	+$30.1K	﹤0.01%	930
2022 Q3	$19K	Buy	631 +108	+21%	+$3.5K	﹤0.01%	1123
2022 Q2	$14K	Buy	+523	New	+$14.1K	﹤0.01%	1101

Other funds holding VIVO

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Blue Trust Inc's VIVO Position: Q2 2023 in Review

Blue Trust Inc sold out of Meridian Bioscience Inc (VIVO) in Q2 2023, closing a stake of 1,487 shares — an estimated $49K sold.

Blue Trust Inc first reported a position in VIVO in Q2 2022 and held it in 4 quarters. The position peaked at $49K in Q1 2023. 1 fund tracked by Wall St. Rank holds VIVO as of Q2 2023.

Blue Trust Inc reported no remaining Meridian Bioscience Inc position as of Q2 2023 after selling out during the quarter.
Blue Trust Inc sold 1,487 Meridian Bioscience Inc shares in Q2 2023, an estimated $49K.
Blue Trust Inc first reported a position in Meridian Bioscience Inc in Q2 2022 and held it in 4 quarters.
Blue Trust Inc's Meridian Bioscience Inc position peaked at $49K in Q1 2023.
1 fund tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2023.

Based on Blue Trust Inc's 13F filing for Q2 2023, filed 14 Jul 2023.